Pacific Biosciences Of California (PACB) Treasury Shares (2018 - 2026)

Pacific Biosciences Of California's Treasury Shares history runs 9 years deep, the most recent figure standing at $19.2 million for Q1 2026.

• On a quarterly basis, Treasury Shares rose 4804.59% year-over-year to $19.2 million in Q1 2026; TTM through Mar 2026 was $19.2 million, a 4804.59% increase from a year earlier, with the FY2025 full-year figure at $392000.0, changed 0.0% from the prior year.
• Treasury Shares rose to $19.2 million in Q1 2026 per PACB's latest filing, from $392000.0 in the prior quarter.
• Across five years, Treasury Shares topped out at $19.2 million in Q1 2026 and bottomed at $8392.0 in Q2 2022.
• The 5-year median for Treasury Shares is $541000.0 (2023), against an average of $5.4 million.
• Across the five-year window, Treasury Shares tumbled 99.88% in 2022 and soared 150555.39% in 2023, its largest moves.
• Year by year, Treasury Shares stood at $8.5 million in 2022, then surged by 32.49% to $11.3 million in 2023, then slumped by 96.53% to $392000.0 in 2024, then changed by 0.0% to $392000.0 in 2025, then surged by 4804.59% to $19.2 million in 2026.
• Per Business Quant, the three latest PACB Treasury Shares figures stand at $19.2 million (Q1 2026), $392000.0 (Q4 2025), and $392000.0 (Q3 2025).